Although STZ-treated Gcgr-/- mice remained normoglycemic, as previously reported (Conarello et al., 2006; Lee et al., 2011; 2012), they developed severe hyperglycemia after insulin receptor inhibition (continuous vs dotted purple line). This evidence concerns the gene GCGR and Hyperglycemia.